相关实验视频

Updated: Jan 11, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

P-tau217测试对表现为认知障碍的患者预期治疗的影响:一项随机临床实用性研究

Samantha C Burnham¹, Haoyan Hu¹, Yifeng Tang¹

¹Eli Lilly and Company Indianapolis Indiana USA.

Alzheimer's & dementia (Amsterdam, Netherlands)

|November 19, 2025

概括

在217 (p-tau217) 酸化的血测试显著影响阿尔茨海默病的诊断. 这种微创工具通过改变工作诊断和增加信心,改善患者管理来帮助医疗保健提供者.

科学领域:

神经学神经学
生物标志物研究生物标志物研究
阿尔茨海默氏症疾病的诊断方法

背景情况:

血生物标志物为阿尔茨海默病 (AD) 病理检测提供了一种最小侵入性的方法.
血生物标记物的临床实用性,如p-tau217,需要进一步评估.

研究的目的:

评估217 (p-tau217) 试验时化的血的临床效用.
评估p-tau217结果对医疗保健提供者在认知障碍患者的诊断思维的影响.

主要方法:

一项正在进行的,开放的,随机的,多中心的,前性的,观察性研究.
609名认知障碍患者被随机分为p-tau217测试 (n=391) 和未测试 (n=218) 组.
根据p-tau217结果,评估工作诊断和诊断信心的变化.

主要成果:

在70.5%的患者中,当p-tau217结果与初始诊断不一致时,工作诊断发生了变化.
当p-tau217结果与工作诊断一致时,诊断信心增加了15.7%.
与未经测试的患者中的15.6%相比,p-tau217测试对诊断决策产生了重大影响.

结论:

血p-tau217测试在诊断阿尔茨海默病时临床上很有用.
P-tau217的结果改变了医疗保健提供者的工作诊断和预期的患者管理.
P-tau217测试提高了在接受认知障碍评估的患者的诊断信心.

关键词:

阿尔茨海默氏症的疾病是阿尔茨海默氏症.血生物标志物血生物标志物在p-tau217中

更多相关视频

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid

A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid

Published on: September 3, 2021

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Kendall's Tau Test

Kendall's Tau Test

Kendall's tau test, also known as the Kendall rank coefficient test, is a nonparametric method for assessing association between two variables. This test is particularly useful for identifying significant correlations when the distributions of the sample and population are unknown. Developed in 1938 by the British statistician Sir Maurice George Kendall, the tau coefficient (denoted as τ) serves as a rank correlation coefficient, with values ranging from -1 to +1.
A τ value of +1 indicates...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.